In Reply Our article1 highlights that in aggregate little changes to reduce the potential fracture risk associated with prescription medications after a fragility fracture among older adults in the United States. The population put at-risk (ie, proportion of people exposed to potentially harmful medications) does not change. That aggregate finding masks, however, that the specific individuals exposed may change because some people cease harmful drugs while others begin them.
Julie Bynum, Jeffrey Munson, Anna N. A. Tosteson. Where Is the Geriatrician?—Reply. JAMA Intern Med. 2017;177(3):442–443. doi:10.1001/jamainternmed.2016.8856